The 50-Year Legacy of the Hellenic Cytology Society

The Hellenic Society of Clinical and Molecular Cytology recently celebrated its 50th anniversary, marking a significant milestone in cytopathology clinical practice and public health. This celebration reflects on five decades of service to the Greek population and the global impact of cytological advancements. Initially, the specialty was established in 1962 through the dedicated efforts of Dr. George Papanicolaou's students. In 1975, the society was formally created to promote continuous education and raise the visibility of the specialty within the medical community. Consequently, it has played a vital role in defining the diagnostic standards used in clinics today.

Current Standards in Cytopathology Clinical Practice

Today, the society comprises 300 active members who manage a diverse range of specimens using advanced diagnostic methods. Modern cytopathology clinical practice in Greece now includes interventional cytopathology and the integration of molecular ancillary techniques. Furthermore, the society is a cornerstone of the national screening program, ensuring high-quality assurance through rigorous laboratory protocols. These efforts have significantly improved the early detection of malignancies, particularly in women's health. Additionally, the society maintains strong international liaisons to stay at the forefront of global diagnostic innovations.

The Future: Integration with Anatomic Pathology

Looking ahead, the landscape of diagnostic medicine is undergoing a transformative shift. Following national guidelines issued in 2024, a working committee has proposed merging cytopathology with anatomic pathology in Greece. This strategic move aims to create a unified diagnostic framework that leverages digital pathology and comprehensive tissue analysis. Moreover, such integration is expected to streamline workflows and enhance diagnostic accuracy by providing a holistic view of patient pathology. Notably, this transition reflects a global trend where traditional cytology boundaries are expanding to include sophisticated molecular and digital tools.

Frequently Asked Questions

Why is cytopathology being merged with anatomic pathology?

The merger aims to unify diagnostic workflows, particularly with the rise of digital pathology and molecular testing. By combining these fields, clinicians can achieve a more comprehensive and accurate diagnosis through integrated reporting.

What role does the Hellenic Cytology Society play in national screening?

The society oversees the quality assurance of laboratory practices and provides the expertise required for the national screening programs, which are essential for the early detection of cancers like cervical cancer.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical concerns. Refer to the latest local and national guidelines for clinical practice.

References

Nasioutziki M et al. Honoring 50 Years of the Hellenic Cytology Society: A Milestone Event-A Review of the History, Current Practice, and Future Perspectives of Cytology in Greece. Diagn Cytopathol. 2026 Feb 22. doi: 10.1002/dc.70105. PMID: 41725063.

Proscia. Breaking the Cytology Barrier: Unified Digital Pathology at Enterprise Scale. September 22, 2025.

Saini T et al. Digital cytology: Current status and future prospects. Diagn Cytopathol. 2023 Jan. doi: 10.1002/dc.25099.